mRNA vaccine and therapy market value worldwide 2020-2030

Published by
Matej Mikulic
,
Jun 7, 2024
The value of the global mRNA combined vaccines and therapies market is forecast to reach around 68 billion U.S. dollars by the end of 2030. In 2020, the market was estimated at approximately 27 billion U.S. dollars. This would represent a compound annual growth rate of nearly nine percent between 2020 and 2030.
More information on the global mRNA vaccines and therapies market can be found here.

Total global mRNA vaccine and therapy market value from 2020 to 2030 (in billion U.S. dollars)

CharacteristicMarket value in billion U.S. dollars
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Showing entries 1 to 11 (11 entries in total)
Statistic: Total global mRNA vaccine and therapy market value from 2020 to 2030 (in billion U.S. dollars)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2023

Region

Worldwide

Survey time period

as of May 2023

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Medical biotech industry "

Other statistics that may interest you Medical biotech industry

Global overview

7

Research & development

6

R&D country comparison

3

Products

4

Funding/M&A/IPOs

5

Focus: U.S. companies

6

Focus: RNA/mRNA

3

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.